Back to calendar
Keros Therapeutics, Inc. (KROS) Earnings
KROS reports earnings on Monday, August 3, 2026
earnings report
August 3, 2026 · After Market Close
Q2 2026
Est. EPS: $-0.96
Actual EPS: $-1.45
EPS surprise: -8.21%
Company overview
Market Cap$211.2M
PriceUSD 10.65
EPS (TTM)-3.70
52-week high22.55
52-week low9.69
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees78